Evidence map›Paper›PMID 35266013›Full record

ArticleMolecular medicine reports2022

[Retracted] MicroRNA‑181 serves an oncogenic role in breast cancer via the inhibition of SPRY4.

Yifu Tian, Xiaodan Fu, Qingling Li, Ying Wang, Dan Fan, Qin Zhou, Weilu Kuang, Liangfang Shen

Abstract readRetraction Notice
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecular medicine reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Yifu TianDepartment of Pathology, Xiangya Hospital of Central South University, Changsha, Hunan 410008, P.R. China.
Xiaodan FuDepartment of Pathology, Xiangya Hospital of Central South University, Changsha, Hunan 410008, P.R. China.
Qingling LiDepartment of Pathology, Xiangya Hospital of Central South University, Changsha, Hunan 410008, P.R. China.
Ying WangDepartment of Oncology, Xiangya Hospital of Central South University, Changsha, Hunan 410008, P.R. China.
Dan FanDepartment of Oncology, Xiangya Hospital of Central South University, Changsha, Hunan 410008, P.R. China.
Qin ZhouDepartment of Oncology, Xiangya Hospital of Central South University, Changsha, Hunan 410008, P.R. China.
Weilu KuangDepartment of Oncology, Xiangya Hospital of Central South University, Changsha, Hunan 410008, P.R. China.
Liangfang ShenDepartment of Oncology, Xiangya Hospital of Central South University, Changsha, Hunan 410008, P.R. China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Following the publication of this paper, it was drawn to the Editors' attention by a concerned reader that the Transwell cell migration assay data shown in Figs. 3B and 9B were strikingly similar to data appearing in different form in other articles by different authors. Owing to the fact that the contentious data in the above article had already been published elsewhere, or were already under consideration for publication, prior to its submission to

Indexed as

breast cancerinvasionmicroRNAmigrationproliferationprotein sprouty homolog 4

Identifiers

PMID35266013
PMCPMC8941372

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.